Jason Coloma V - 02 Sep 2026 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Sep 2026, 16:24:27 UTC
Prior SEC filing
03 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Courtney Phillips, as attorney-in-fact

Key filing fact

Jason Coloma V filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 04 Sep 2026.

Key facts

  • This page summarizes Jason Coloma V's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Sep 2026, 16:24.

Change

  • Previous filing in this sequence was filed on 03 Sep 2026.
  • Current net transaction value: -$593,955.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001676170 Primary reporting owner

Coloma Jason V

Relationship
Chief Executive Officer, Director
Address
C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Signature
/s/ Courtney Phillips, as attorney-in-fact
Signature date
04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MAZE transaction

Common Stock

Sale

Transaction value
$259,856
Shares
-9,852
Change %
-20%
Price
$26.38
Shares after
40,148
Date
02 Sep 2026
Ownership
Direct
Footnotes
F1, F2
MAZE transaction

Common Stock

Sale

Transaction value
$37,292
Shares
-1,375
Change %
-3.4%
Price
$27.12
Shares after
38,773
Date
02 Sep 2026
Ownership
Direct
Footnotes
F1, F3
MAZE transaction

Common Stock

Sale

Transaction value
$293,482
Shares
-11,282
Change %
-29%
Price
$26.01
Shares after
27,491
Date
03 Sep 2026
Ownership
Direct
Footnotes
F1, F4
MAZE transaction

Common Stock

Sale

Transaction value
$3,325
Shares
-129
Change %
-0.47%
Price
$25.77
Shares after
27,362
Date
03 Sep 2026
Ownership
Direct
Footnotes
F1
MAZE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,151
Date
02 Sep 2026
Ownership
The Coloma 2021 Irrevocable Trust
Footnotes
F5
MAZE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
223,355
Date
02 Sep 2026
Ownership
Coloma Family Trust
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.

Footnote F5

These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.

Footnote F6

These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .